RxDoctor Payments DataLook up a doctor →

AMELUZ: payments to doctors

Payments that named AMELUZ as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$1.2M
Providers
8,312
Transactions
24,550
Average per transaction
$50

The per-transaction average — $50 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,312 providers the average total is $147, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Biofrontera Inc.$1,214,59299.4%
Biofrontera Bioscience GmbH$7,0990.6%
← All drugs & devices